Why Some Patients Undergoing Lipoprotein Apheresis Therapy Develop New Cardiovascular Events?

Lipoprotein apheresis (LA) is an effective tool to reduce cardiovascular events (CVEs) in high-risk patients with elevations of low density lipoprotein-cholesterol (LDL-C) and/or Lipoprotein(a) (Lp(a)). All patients included into this retrospective analysis had experienced CVEs before the start of t...

Descripción completa

Detalles Bibliográficos

Autores principales:	Ulrich Julius, Solveig Kuss, Sergey Tselmin, Ulrike Schatz, Stefan R. Bornstein
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2020-07-01
Colección:	Journal of Cardiovascular Development and Disease
Materias:	lipoprotein apheresis cardiovascular events LDL-cholesterol LDL-cholesterol corrected for its content in Lipoprotein(a) particles Lipoprotein(a) targets for LDL-cholesterol
Acceso en línea:	https://www.mdpi.com/2308-3425/7/3/25
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!